{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:26:00Z","timestamp":1772000760495,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to identify factors associated with diabetic macular edema (DME) presence in working-age (18\u201360 years) patients with type 2 diabetes mellitus (T2DM) by developing a model that integrates HbA1c, renal function (eGFR), and hemodynamic parameters (SBP). The model addresses critical gaps in current screening strategies by using routinely available biomarkers, thereby enabling non-ophthalmologists to efficiently identify high-risk individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study prospectively collected data from 490 patients with type 2 diabetes mellitus (T2DM), aged 18\u201360 years, who were consecutively enrolled at a single medical center between January 2020 and March 2025. The participants were randomly allocated into two groups: a training cohort (n=343) and a validation cohort (n=147). Predictors were selected via LASSO regression with 10-fold cross-validation from an initial set of 19 variables, encompassing renal function, metabolic parameters, and hemodynamic indices. Subsequently, a multivariate logistic regression model was developed and illustrated through a nomogram. The model\u2019s predictive accuracy was evaluated through receiver operating characteristic (ROC) curves (AUC), calibration curves, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall prevalence of DME in the study cohort was 15.71% (77 of 490). Four predictors independently associated with DME were identified using LASSO regression, namely diabetes duration (OR = 1.460, 95% CI: 1.212\u20131.457), SBP (OR = 1.066, 95% CI: 1.037\u20131.095), eGFR (OR = 0.938, 95% CI: 0.916\u20130.961), and HbA1c (OR = 1.484, 95%CI: 1.189\u20131.852). The resulting nomogram exhibited robust discriminatory ability (training AUC = 0.905, 95% CI: 0.858\u20130.951; validation AUC = 0.884, 95% CI: 0.820\u20130.949) and strong calibration performance (Hosmer-Lemeshow test, P = 0.878). DCA further confirmed substantial clinical applicability within a threshold probability range from 2% to 100%, achieving a maximum net benefit of 0.14, thereby potentially preventing unnecessary intervention in 14 out of every 100 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This nomogram effectively integrates HbA1c, renal function, and hemodynamic parameters to identify key factors associated with diabetic macular edema (DME) risk in working-age patients with type 2 diabetes mellitus (T2DM), demonstrating high accuracy. By utilizing routine clinical measures, it facilitates implementation in primary care settings, offering the potential to reduce vision loss through timely referrals. Future multicenter studies are warranted to verify its generalizability and explore its integration with emerging biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1710040","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:32:41Z","timestamp":1771997561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A clinically actionable nomogram integrating HbA1c, renal function, and blood pressure for early prediction of diabetic macular edema in working-age patients with type 2 diabetes"],"prefix":"10.3389","volume":"17","author":[{"given":"Qingchun","family":"Pan","sequence":"first","affiliation":[{"name":"Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renli","family":"Huang","sequence":"additional","affiliation":[{"name":"Longchang People's Hospital, Sichuan","place":["Longchang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingya","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.11.008","article-title":"Persistent diabetic macular edema: definition, incidence, biomarkers, and treatment methods","volume":"68","author":"Sorour","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2020_535","article-title":"Diabetic macular edema: state of art and intraocular pharmacological approaches","volume":"1307","author":"Gurreri","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"The Lancet. Global health"},{"key":"B5","article-title":"Macular edema","volume-title":"Statpearls","author":"Kohli","year":"2025"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2100694","article-title":"Efficacy and safety of intravitreal anti-vegf therapy in diabetic retinopathy: what we have learned and what should we learn further","volume":"22","author":"Uludag","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2021.11.002","article-title":"Optical coherence tomography (Oct) angiolytics: A review of oct angiography quantitative biomarkers","volume":"67","author":"Kalra","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583687","article-title":"The role of inflammation in diabetic retinopathy","volume":"11","author":"Forrester","year":"2020","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: A consensus report by the american diabetes association (Ada) and kidney disease: improving global outcomes (Kdigo)","volume":"45","author":"De Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13480","article-title":"Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy","volume":"12","author":"Lin","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2521150","DOI":"10.1001\/jamanetworkopen.2025.21150","article-title":"Time to progression to proliferative diabetic retinopathy in patients with type 2 diabetes","volume":"8","author":"Kim","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m997","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the american diabetes association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"Bmj"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202002-141ED","article-title":"Methodologic guidance and expectations for the development and reporting of prediction models and causal inference studies","volume":"17","author":"Harhay","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1057\/s41285-017-0055-0","article-title":"In bmi we trust: reframing the body mass index as a measure of health","volume":"16","author":"Gutin","year":"2018","journal-title":"Soc Theory Health"},{"key":"B15","article-title":"Guidelines for clinical diagnosis and treatment of diabetic retinopathy in China (2014)","volume":"50","year":"2014","journal-title":"Chin J Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3760\/cma.j.cn112138-20211027-00751","article-title":"Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group, Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society, Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society, Geriatric Professional Committee of Beijing Medical Award Foundation, & National Clinical Medical Research Center for Geriatric Diseases (PLA General Hospital)","volume":"61","year":"2022","journal-title":"Zhonghua nei ke za zhi"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9010016","article-title":"Glycated hemoglobin (Hba1c) as a biomarker for diabetic foot peripheral neuropathy","volume":"9","author":"Casadei","year":"2021","journal-title":"Diseases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111589","article-title":"International diabetes federation position statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes","volume":"209","author":"Bergman","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"Acg clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41581-019-0191-y","article-title":"Measured and estimated glomerular filtration rate: current status and future directions","volume":"16","author":"Levey","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148272","article-title":"Serum cholesterol levels and risk of cardiovascular death: A systematic review and a dose-response meta-analysis of prospective cohort studies","volume":"19","author":"Jung","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2020.1762918","article-title":"Serum albumin, cardiometabolic and other adverse outcomes: systematic review and meta-analyses of 48 published observational cohort studies involving 1,492,237 participants","volume":"54","author":"Seidu","year":"2020","journal-title":"Scand Cardiovasc J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","article-title":"Diabetic retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.21101\/cejph.a7838","article-title":"Diabetes mellitus and its influence on the incidence and process of diabetic retinopathy","volume":"31","author":"Por\u00e1\u010dov\u00e1","year":"2023","journal-title":"Cent Eur J Public Health"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213362","article-title":"Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications","volume":"11","author":"Zhang","year":"2022","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.22336\/rjo.2019.52","article-title":"Variability of diabetic macular edema in correlation with hypertension retinopathy in patients with diabetes mellitus and essential hypertension","volume":"63","author":"Stana","year":"2019","journal-title":"Rom J Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"Cd006127","DOI":"10.1002\/14651858.CD006127.pub3","article-title":"Blood pressure control for diabetic retinopathy","volume":"3","author":"Do","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1128811","article-title":"Mechanisms of macular edema","volume":"10","author":"Haydinger","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"26098","DOI":"10.1038\/s41598-024-77530-3","article-title":"Association between renal function and the treatment of diabetic macular edema in long-term cohort study","volume":"14","author":"Chou","year":"2024","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073645","article-title":"Vascular permeability in diseases","volume":"23","author":"Wautier","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad581","article-title":"Diabetic macular edema is predictive of renal failure in patients with diabetes mellitus and chronic kidney disease","volume":"109","author":"Ou","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5581679","article-title":"Association of abnormal renal profiles with subretinal fluid in diabetic macular edema","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Ophthalmol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02173-5","article-title":"Association of renal function with diabetic retinopathy and macular oedema among chinese patients with type 2 diabetes mellitus","volume":"37","author":"Wang","year":"2023","journal-title":"Eye (Lond)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06132-5","article-title":"Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: A real-world data study from a global federated database","volume":"67","author":"Eleftheriadou","year":"2024","journal-title":"Diabetologia"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051502","article-title":"Relationship between diabetic nephropathy and development of diabetic macular edema in addition to diabetic retinopathy","volume":"11","author":"Suzuki","year":"2023","journal-title":"Biomedicines"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.Ijo_345_23","article-title":"Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema","volume":"71","author":"Bhutia","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004381","article-title":"DEXAMETHASONE INTRAVITREAL INJECTION IN DIABETIC PATIENTS UNDERGOING CATARACT SURGERY: an updated literature review","volume":"45","author":"Meduri","year":"2025","journal-title":"Retina (Philadelphia Pa.)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/11206721241235242","article-title":"Clinical and optical coherence tomography biomarkers as prognostic factors in dexamethasone intravitreal implant for diabetic macular edema","volume":"34","author":"Oliverio","year":"2024","journal-title":"Eur J Ophthalmol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1710040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:32:43Z","timestamp":1771997563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1710040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":38,"alternative-id":["10.3389\/fendo.2026.1710040"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1710040","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"1710040"}}